RD

Rose Davis

Investment Strategist

San Francisco Bay Area

Invests in

Stages:

Locations:

  • Min Investment:

    $250,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $2,625,000.00

Work Experience

  • Investment Strategist

    2024

2021 - 2024

  • Healthtech Advisor

    2023 - 2024

  • Investor

    2021 - 2023

    Sourced Investments: Superscript (stealth), RightHub (Board Director), Clock.Bio, Commons Clinic (angel) Other Investments: Hearty, Dayhoff (stealth), Landbase (stealth), Bit.Bio Portfolio coverage: Relation Therapeutics, ASYSTEM (Board Director), Fork & Good and Lindus Health

  • Industry Partnerships and Commercialisation, Faculty of Medicine

    2020 - 2021

    Key projects: AI for Alzheimer’s Disease, AI for heart disease, AI for sarcopenia, Surgery simulator, AI for Metabolomic data

  • Investment Associate

    2018 - 2020

  • Head of Strategy and Operations

    2018 - 2020

  • Research Assistant

    2017 - 2018

2016 - 2018

  • Research Fellow

    2016 - 2018

  • Research Assistant

    2016 - 2018

    Worked with Director of Yale New Haven Hospital’s Women’s Heart and Vascular Program, Dr. Lisa Freed, at the clinic during patient visits

2017 - 2017

  • Clinical Innovation Intern

    2017 - 2017

    Merged with Signify Health, acquired by CVS Health

2016 - 2017

  • Research Assistant

    2016 - 2017